Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
With 3.45 million active cases, India recorded 357,229 new infections over the last 24 hours, while deaths rose 3,449 for a count of 222,408, health ministry data showed.
The drugmaker said it will work urgently to increase the supply multifold over the coming weeks.
On Monday, the country's drug regulator gave emergency use approval to Lilly's treatment, baricitinib, for its use in hospitalized COVID-19 patients requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation.
The drug will be used in combination with Gilead Sciences's COVID-19 drug remdesivir.
Lilly is offering donations of its rheumatoid arthritis drug baricitinib for COVID-19 treatment to the Indian government through aid organization Direct Relief.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
'Rohit Sharma Is Not Indispensable": World Cup Winner's Blunt Take On India Skipper Missing Perth Test India 'Unsatisfied' With UNSC's Pace Of Progress, Says Stuck In 1945 Ajit Agarkar To Stay Back For Australia Tests; Big Call On Virat Kohli, Rohit Sharma Expected: Report UP Polls: BJP Flags Burqa Voters, Samajwadi Party Says Cops Can't Check ID AR Rahman, Wife Saira Announce Separation After 29 Years Of Marriage "Rama Krishna Hari": Supriya Sule On Cousin Ajit Pawar's Bitcoin Row Remark 'Prasad' Sold At Baba Balak Nath Temple Found Unfit For Consumption Swiggy Instamart Sending Free 'Tinday' With Some Mumbai Orders. Here's Why 'I'm A Celebrity' Star Tulisa Reveals She Is Demisexual. What Is It Track Latest News Live on NDTV.com and get news updates from India and around the world.